Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUSStandard

ERTAPENEM SODIUM

ERTAPENEM SODIUM

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ERTAPENEM SODIUM is listed in Drugs@FDA under application 218067 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ERTAPENEM SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 1GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2024-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERTAPENEM SODIUM is listed in Drugs@FDA under application 218067 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ERTAPENEM SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 1GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2024-10-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.